- Pure Extracts (PULL) subsidiary Pure Extracts Manufacturing has received a license from Health Canada for the sale of cannabis
- The company can now sell cannabis extract products to authorized distributors and retailers nationwide
- The license allows Pure Extracts to potentially phase out its distribution partner in British Columbia, Alberta, Saskatchewan and Ontario
- Pure Extracts Technologies is a plant-based extraction company based in Whistler, British Columbia
- Pure Extracts (PULL) is up by 3.9 per cent and is currently trading at $0.40 per share
Pure Extracts (PULL) subsidiary Pure Extracts Manufacturing has received a license from Health Canada for the sale of cannabis.
The subsidiary was able to amend its existing license to sell cannabis extract products to provincially authorized distributors and retailers nationwide, as well as to license holders for the sale of medical cannabis extracts.
The approval comes after Health Canada’s intensive review of the company’s internal systems, processes, products and packaging.
The license will allow Pure Extracts to reach every province and territory across Canada without the help of an intermediary. The company currently relies on a distribution partner to fulfill purchase orders from British Columbia, Alberta, Saskatchewan and Ontario.
Ben Nikolaevsky, Pure Extracts’ CEO, remarked,
“Our sales license approval is the culmination of months of hard work and determination by our entire staff with their tireless concentration on quality and consistency. With sales of recreational products rising steadily as new cannabis 2.0 products take hold in the marketplace, this approval paves the way for Pure Extracts to expand both our proprietary in-house brands like Pure Pulls and Pure Chews as well as the other white label products that we are bringing to market.”
Pure Extracts Technologies is a plant-based extraction company based in Whistler, British Columbia.
Pure Extracts (PULL) is up by 3.9 per cent and is currently trading at $0.40 per share as of 11:21 am ET.
